Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations
Status:
Terminated
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of CTP-656 in patients with cystic fibrosis
(CF) who have a cystic fibrosis transmembrane conductance regulator (CFTR) gating mutation.